Could a simple blood test detect breast cancer? new study aims to find out.
NCT ID NCT07374796
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new blood test that looks for specific DNA changes (called epigenetic changes) to help diagnose breast cancer. Researchers will collect blood samples from 450 people, including those with breast cancer, healthy volunteers, and others, and follow them for about 5 years. The goal is to see if this blood test can accurately detect breast cancer, potentially offering a simpler way to diagnose the disease in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER (LOCALLY ADVANCED OR METASTATIC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Maryland Baltimore Washington Medical Center
Glen Burnie, Maryland, 21061, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pulsing light on the scalp boost brain performance?
- Can text messages or nurse visits boost breast cancer screening?
- Can heavy water reveal how the liver makes fat?
- Which bridge exercise fires up your muscles most? a study investigates
- Triple-Action antibody takes aim at advanced breast cancer
- Empowerment, not just education, may boost breast cancer screening in latinas